Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

Lancet

Volumn 353, Issue 9151, 1999, Pages 459-461

  Schreiber, Stefan ^a   Nikolaus, Susanna ^a   Hampe, Jochen ^a   Hämling, Jens ^c   Koop, Irmtraut ^b   Groessner, Birte ^a   Lochs, Heribert ^b   Raedler, Andreas ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Tabea Centre for Inflammatory Bowel Disease   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; INTERLEUKIN 1BETA; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CROHN DISEASE; CYTOKINE PRODUCTION; DEMOGRAPHY; HUMAN; HUMAN CELL; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; RELAPSE; REMISSION;

EID: 0033528272     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03339-X     Document Type: Article

References (19)

1. Munkholm P., Langholz E., Davidsen M., Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 30:1995;699-706.
2. Greenberg G.R., Feagan B.G., Martin F.et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo controlled dose-ranging study. Gastroenterology. 110:1996;45-51.
3. Hanauer S.B. Drug therapy: inflammatory bowel disease. N Engl J Med. 334:1996;841-848.
4. Belluzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 334:1996;1560-1567.
5. Wright J.P., Young G.O., Tigler-Wybrandi N. Predictors of acute relapse of Crohn's disease: a laboratory and clinical study. Dig Dis Sci. 32:1987;164-170.
6. Gendre J.P., Mary J.Y., Florent C.et al. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter, placebo controlled study. Gastroenterology. 104:1993;435-439.
7. Brignola C., Campieri M., Bazzochi G., Farruggia P., Tragnone A., Lanfranchi G.A. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology. 91:1986;1490-1494.
8. Ligumsky M., Simon P.L., Karmeli F., Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease: enhanced production during active disease. Gut. 31:1990;686-689.
9. MacDonald T.T., Hutchings P., Choy M.Y., Murch S., Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 81:1990;301-305.
10. Reinecker H.-C., Steffen M., Witthoeft T.et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 94:1993;174-181.
11. Stack W.A., Mann S.D., Roy A.J.et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet. 349:1997;521-524.
12. Targan S.R., Hanuaer S.B., van Deventer S.J.H.et al. A short term study of chimeric monoclonal antibody cA2 to tumour necrosis factor α for Crohn's disease. N Engl J Med. 337:1997;1029-1035.
13. Moreland L.W., Baumgartner S.W., Schiff M.H.et al. Treatment of rheumatoid arthritis with a recombinant human tumour necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 337:1997;141-147.
14. Elliott M.J., Maini R.N., Feldmann M.et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet. 344:1994;1105-1110.
15. Best W.R., Becktel J.M., Singleton J.W., Kern F.Jr. Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology. 70:1976;439-444.
16. Schreiber S., Heinig T., Thiele H.G., Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology. 108:1995;1434-1444.
17. Lillifors H.W. On the Kolmogorov-Smirnov test for normality with mean and variance unknown. J Am Stat Assoc. 64:1967;399-402.
18. Wyatt J., Vogelsang H., Hubl W., Waldhoer T., Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet. 341:1993;1437-1439.
19. Riley S.A., Mani V., Goodman M.J., Dutt S., Herd M.E. Microscopic activity in ulcerative colitis: what does it mean? Gut. 32:1991;174-178.